Safety and Efficacy Study of IPX159 in Restless Legs Syndrome (RLS)

PHASE2CompletedINTERVENTIONAL
Enrollment

159

Participants

Timeline

Start Date

November 30, 2011

Primary Completion Date

February 28, 2013

Study Completion Date

February 28, 2013

Conditions
Restless Legs Syndrome
Interventions
DRUG

IPX159

DRUG

Placebo

Trial Locations (38)

10168

Fieve Clinical Research, Inc., New York

11772

Comprehensive Multiple Sclerosis Care Center, Patchogue

18411

Sleep Lab of Northeastern Pennsylvania, Clarks Summit

21224

Johns Hopkins Bayview Medical Center Campus, Baltimore

27607

Raleigh Neurology Associates, P.A., Raleigh

27612

Wake Research Associates, LLC, Raleigh

28401

PMG Research of Wilmington, LLC, Wilmington

29201

SleepMed of SC, Columbia

29464

Coastal Carolina Research Center, Mt. Pleasant

30342

NeuroTrials Research Inc, Atlanta

30912

Georgia Health Sciences University, Augusta

31201

SleepMed of Central Georgia, Macon

32174

Neurology Associates of Ormond Beach, Ormond Beach

33009

MD Clinical, Hallandale

33511

PAB Clinical Research, Brandon

34684

Resurgence Group, Palm Harbor

35294

University of Alabama at Birmingham, Brimingham

38163

University of Tennesee Health Science Center, Memphis

40217

Kentucky Research Group, Louisville

41017

Community Research, Crestview Hills

45255

Community Research, Cincinnati

48334

QUEST Research Institute, Farmington Hills

52242

University of Iowa Hospitals and Clinics, Iowa City

72211

Preferred Research Partners, Inc., Little Rock

77074

Clinical Trial Network, Houston

78205

Paragon Research Center, LLC, San Antonio

78731

Future Research Trials of Neurology, Austin

79410

Bhupesh Dihenia, M.D., P.A., Lubbock

80012

Sleep-Alertness Disorder Center, Aurora

90404

Neurological Research Institute, Santa Monica

90806

Collaborative Neuroscience Network, Inc., Long Beach

92037

Scripps Clinic, La Jolla

92056

The Research Center of Southern California, Oceanside

94063

Stanford Center for Human Sleep Research, Redwood City

98122

Sleep Medicine Associates, Seattle

02135

Sleep Health Centers, LLC, Brighton

02301

Beacon Clinical Research, LLC, Brockton

08540

Global Medical Institutes, LLC, Princeton

Sponsors
All Listed Sponsors
lead

Impax Laboratories, LLC

INDUSTRY

NCT01521663 - Safety and Efficacy Study of IPX159 in Restless Legs Syndrome (RLS) | Biotech Hunter | Biotech Hunter